Search

Your search keyword '"Bosteels C."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Bosteels C." Remove constraint Author: "Bosteels C."
40 results on '"Bosteels C."'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

6. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

8. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

9. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

10. CCR2-and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01

12. CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01

13. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

14. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

15. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

16. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

17. Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome.

18. Growing from common ground: nontuberculous mycobacteria and bronchiectasis.

19. A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

20. LXR signaling controls homeostatic dendritic cell maturation.

21. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.

22. Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.

23. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.

24. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

25. Isolation of Conventional Murine Lung Dendritic Cell Subsets.

26. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

27. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.

28. Local immune response to food antigens drives meal-induced abdominal pain.

29. CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01.

30. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.

31. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.

32. Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.

33. Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.

34. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.

35. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.

36. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.

37. Transcriptional regulation of DC fate specification.

38. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis.

39. Isolation of Conventional Murine Lung Dendritic Cell Subsets.

40. Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain.

Catalog

Books, media, physical & digital resources